This is a StreetInsider.com Premium Only Page

Kirin Holdings Company, Limited Sponsored ADR (KNBWY) – StreetInsider.com Reports

Feb 21, 2024 10:58 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,200 at Bernstein

Oct 10, 2023 12:05 PM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,200 at JPMorgan

Oct 4, 2023 05:09 AM Goldman Sachs Starts Kirin Holdings Co Ltd (2503:JP) (KNBWY) at Sell

Sep 25, 2023 06:56 AM Ardelyx (ARDX) Announces Tenapanor for Hyperphosphatemia Approved in Japan

May 31, 2023 11:33 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,850 at Nomura/Instinet

Mar 23, 2023 12:10 PM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,750 at Nomura/Instinet

Mar 13, 2023 12:07 PM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,200 at Credit Suisse

Dec 5, 2022 05:03 PM MEI Pharma (MEIP) and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting

Nov 30, 2022 04:55 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,850 at Nomura/Instinet

Nov 9, 2022 10:59 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,400 at Bernstein

Oct 18, 2022 11:51 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,400 at JPMorgan

Sep 27, 2022 03:02 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,700 at Citi

Sep 20, 2022 05:43 AM Goldman Sachs Upgrades Kirin Holdings Co Ltd (2503:JP) (KNBWY) to Buy

Sep 20, 2022 05:43 AM Goldman Sachs Upgrades Kirin Holdings Co Ltd (2503:JP) (KNBWY) to Buy

Jun 29, 2022 04:21 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,440 at CLSA

Jun 23, 2022 12:41 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,100 at Credit Suisse

May 17, 2022 08:03 AM Mereo BioPharma (MREO) Announces Appointment of Dr. Abdul Mullick to Board of Directors

May 9, 2022 09:15 AM Cumberland Pharmaceuticals (CPIX) Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso

Apr 20, 2022 12:47 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,100 at JPMorgan

Mar 13, 2022 03:04 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,200 at Goldman Sachs

Feb 15, 2022 06:39 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,100 at CLSA

Jan 7, 2022 05:37 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,200 at Goldman Sachs

Jan 4, 2022 09:15 AM Cumberland Pharmaceuticals (CPIX) Acquires Sancuso From Kyowa Kirin North America

Nov 30, 2021 07:35 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,200 at JPMorgan

Sep 8, 2021 10:40 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,300 at JPMorgan

Sep 6, 2021 08:26 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,350 at Morgan Stanley

May 19, 2021 05:03 PM MEI Pharma (MEIP) and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2021

May 12, 2021 10:02 AM MEI Pharma (MEIP), Kyowa Kirin to Present Clinical Data from Phase 1b Study of Zandelisib in Combination with Zanubrutinib at the European Hematology Association 2021 Virtual Congress

Apr 27, 2021 03:16 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY3,000 at Macquarie

Mar 11, 2021 07:11 AM Goldman Sachs Downgrades Kirin Holdings Co Ltd (2503:JP) (KNBWY) to Neutral

Mar 1, 2021 05:52 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY3,100 at Nomura/Instinet

Nov 24, 2020 10:51 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,300 at JPMorgan

Oct 12, 2020 08:07 AM Ardelyx (ARDX) Announces Data Supporting Efficacy and Safety of Tenapanor to be Presented at ASN

Apr 14, 2020 07:06 AM MEI Pharma (MEIP), Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401

Mar 2, 2020 05:09 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Lowered to JPY2,900 at Citi

Feb 27, 2020 08:06 AM Ultragenyx Pharma (RARE), Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita for TIO

Nov 7, 2019 06:31 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,550 at CLSA

Sep 10, 2019 09:04 AM Ultragenyx Pharma (RARE), Kyowa Kirin Announce Intent to Submit sBLA to U.S. FDA for Crysvita in TIO

Aug 1, 2019 06:36 AM Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO Oncology (AVEO)

Nov 5, 2018 08:04 AM MEI Pharma (MEIP), Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan

Oct 17, 2018 07:06 AM Macquarie Starts Kirin Holdings Co Ltd (2503:JP) (KNBWY) at Outperform

Feb 23, 2018 08:07 AM Kyowa Kirin, Ultragenyx (RARE) Announce Crysvita Receives Conditional Marketing Authorisation in Europe for Treatment of X-Linked Hypophosphatemia in Children

Dec 5, 2016 07:51 AM ArQule (ARQL) Announces Presentation of ARQ 092 Data in SCD at ASH 2016

Dec 5, 2016 06:13 AM ArQule (ARQL) Presents ARQ 531 Data at ASH 2016

Oct 26, 2016 08:31 AM Ultragenyx Pharma (RARE) Commences KRN23 Phase 3 in XLH

Sep 19, 2016 10:47 AM Ultragenyx Pharma (RARE) Announces Positive, Interim Top-Line Data from KRN23 Phase 2 in XLH

Sep 19, 2016 06:29 AM Ultragenyx Pharma (RARE) Announces Positive Interim Data from KRN23 Phase 2 in TIO

Sep 6, 2016 07:48 AM AstraZeneca (AZN) Announces SIROCCO, CALIMA Trials Met Primary, Key Secondary Endpoints

Aug 23, 2016 08:38 AM Ultragenyx Pharma (RARE) Announces Presentations Highlighting KRN23 at ASBMR Meeting

Jul 19, 2016 04:29 PM Valeant Pharma (VRX) Announces FDA AdCom Recommendation of Brodalumab as Plaque Psoriasis Treatment